For exploratory outcomes, inverse-variance-weighted analyses showed a decreased risk for coronary artery disease as well as an increased risk for type 2 diabetes especially associated with genetic variants related to genetically proxied inhibition of HMG-CoA reductase (Supplementary Table 8). Here, HMGCR is linked to type 2 diabetes mellitus.